Clinical Trial Update: Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated combining radiation therapy with topotecan in patients with non-small cell lung cancer, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED